Biological evaluation and drug delivery application of cationically modified phospholipid polymers

Biomaterials

Volumn 25, Issue 19, 2004, Pages 4785-4796

  Palmer, Rosemary R ^a   Lewis, Andrew L ^a   Kirkwood, Laura C ^a   Rose, Susanna F ^b   Lloyd, Andrew W ^b   Vick, Terry A ^a   Stratford, Peter W ^a  

^a BIOCOMPATIBLES UK LTD   (United Kingdom)

^b UNIVERSITY OF BRIGHTON   (United Kingdom)

Author keywords

Cationic charge; Coronary stent; Drug delivery; Haemocompatibility; Phosphorylcholine coatings; Protein adsorption

Indexed keywords

BIOASSAY; BIOCOMPATIBILITY; BIOPOLYMERS; CHEMICAL ACTIVATION; COAGULATION; DNA; DRUG PRODUCTS; MOLECULAR WEIGHT; PHOSPHOLIPIDS; PROTEINS; SCANNING ELECTRON MICROSCOPY;

BIOMOLECULES; PLASMA COAGULATION TIME;

BIOMATERIALS;

ABCIXIMAB; ALBUMIN; ANGIOPEPTIN; ANTISENSE OLIGODEOXYNUCLEOTIDE; DNA FRAGMENT; FIBRINOGEN; HEPARIN; METHACRYLIC ACID DERIVATIVE; OLIGONUCLEOTIDE; PHOSPHOLIPID; PHOSPHORYLCHOLINE; PLASMID DNA; POLYMER; VASCULOTROPIN;

ABSORPTION; ADSORPTION KINETICS; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BLOOD CLOTTING; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CORONARY STENT; DRUG DELIVERY SYSTEM; DRUG SCREENING; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; HUMAN; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RESTENOSIS; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE ACTIVATION;

ABSORPTION; ADSORPTION; ANIMALS; ARTERIES; BLOOD COAGULATION TESTS; CATIONS; CELLS, CULTURED; CHOLINE; COATED MATERIALS, BIOCOMPATIBLE; CORONARY VESSELS; DRUG DELIVERY SYSTEMS; FIBRINOGEN; HUMANS; MATERIALS TESTING; METHACRYLATES; OLIGONUCLEOTIDES; PHOSPHOLIPIDS; PLATELET ACTIVATION; PROTEIN BINDING; SERUM ALBUMIN; SWINE;

EID: 2342444288     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2003.12.034     Document Type: Article

References (34)

1. Konar N, Nujoma Y, Kim C-J. Ion exchange resins and other polyelectrolytes. In: Tripathy SK, Kumar J, Nalwa HS, editors. Handbook of polyelectrolytes and their applications, vol 3. California: American Scientific Publishers; 2002. p. 47-68.
2. Anand V., Kandarapu R., Garg S. Ion-exchange resins. carrying drug delivery forward Drug Discov Today. 6(17):2001;905-914
3. Sriwongjanya M., Bodmeier R. Effect of ion exchange resins on the drug release from matrix tablets. Eur J Pharm Biopham. 46(3):1998;321-327
4. Zuidam N., Posthuma G., De Vries E.T.J., Crommelin D.J.A., Hennink W.E., Storm G. Effects of physicochemical characteristics of poly(2-(dimethylamino) ethyl methacrylate)-based polyplexes on cellular association and internalisation. J Drug Target. 8(1):2000;51-66
5. Sigurdsson H.H., Knudsen E., Loftsson T., Leeves N., Sigurjonsdottir J.F., Masson M. Mucoadhesive sustained drug delivery system based on cationic polymer and anionic cyclodextrin/triclosan complex. J Incl Phenomena Macrocyclic Chem. 44(1-4):2003;169-172
6. Palasis M. For Scimed Life Systems Inc. An implantable polymeric drug delivery device. WO 0205864 A1 2002.
7. Sousa J.E., Costa M.A., Sousa A.G., Abizaid A.C., Seixas A.C., Abizaid A.S., Feres F., Mattos L.A., Falotico R., Jaeger J., Popma J.J., Serruys P.W. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation. 107:2003;381-383
8. Grube E., Silber S., Hauptmann K.E., Mueller R., Buellesfeld L., Gerckens U., Russell M.E. TAXUS I. six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions Circulation. 107:2003;38-42
9. Lewis A.L., Vick T.A. Site-specific drug delivery from coronary stents. Drug Del Systems Sci. 1(3):2001;65-71
10. Lewis A.L., Vick T.A., Collias A.C.M., Hughes L.G., Palmer R.R., Leppard S.W., Furze J.D., Taylor A.S., Stratford P.W. Phosphorylcholine-based polymer coatings for stent drug delivery. J Mater Sci Mater Med. 12:2001;865-870
11. Lewis A.L., Collias A.C.M., Vick T.A., Palmer R.R., Bushby R., Willis S.L., Taylor A.S., Stratford P.W., Leclerc G., Laflamme M., Bouchard M. Local delivery of batimastat from a PC-coated stent reduces neointimal hyperplasia in a porcine coronary model. J Control Release. 87:2003;230-233
12. Lewis AL, Berwick J, Davies MC, Roberts CJ, Wang JH, Small S, Dunn A, Redman RP, Jones SA. Synthesis & characterisation of cationically modified phospholipid polymers. Biomaterials, in press.
13. Clarke S., Davies M.C., Roberts C.J., Tendler S.J.B., Williams P.M., O'Byrne V., Lewis A.L., Russell J.C. Surface mobility of 2-methacryloyloxyethyl phosphorylcholine-co-lauryl methacrylate polymers. Langmuir. 16:2000;5116-5122
14. Lewis A.L., Hughes P.D., Kirkwood L.C., Leppard S.W., Tolhurst L.A., Stratford P.W. Synthesis and characterisation of phosphorylcholine-based polymers useful for coating blood filtration devices. Biomaterials. 21(18):2000;1847-1859
15. Rose SF, Lewis AL, Hanlon GW, Lloyd AW. Biological responses to cationically charged phosphorylcholine-based materials in vitro. Biomaterials, in press.
16. Campbell E.J., O'Byrne V., Stratford P.W., Quirk I., Vick T.A., Wiles M.C., Yianni Y.P. Biocompatible surfaces using methacryloylphosphorylcholine laurylmethacrylate copolymers. ASAIO J. 40(3):1994;853-857
17. Lewis A.L., Cumming Z.L., Goreish H.H., Kirkwood L.C., Tolhurst L.A., Stratford P.W. Crosslinkable coatings from phosphorylcholine-based polymers. Biomaterials. 22:2001;99-111
18. Bonan R., Paiement P., Scortichini D., Cloutier M.J., Leung T.K. Coronary restenosis. evaluation of a restenosis injury index in a swine model Am Heart J. 126(6):1993;1334-1340
19. Lewis A.L., Tolhurst L.A., Stratford P.W. Analysis of a phosphorylcholine-based polymer coating on a coronary stent pre- and post-implantation. Biomaterials. 23:2002;1697-1706
20. Porssa M, McNeillis PM, Freeman RNT. For Biocompatibles Ltd., US 6, 251, 964, 2001.
21. Armstrong J., Gunn J., Arnold N., Malik N., Chan K.H., Vick T.A., Stratford P.W., Cumberland D.C., Holt C.M. Angiopeptin-eluting stents. observations in human vessels and pig coronary arteries J Invasive Cardiol. 14:2002;230-238
22. 32P-oligonucleotide-mediating beat particle delivery to prevent restenosis. Cardiovasc Radiat Med. 2(1):2001;51
23. Lewis A.L. Phosphorylcholine-based polymers and their use in the prevention of biofouling. Coll Surf B: Biointerfaces. 18:2000;261-275
24. Ueda T., Ishihara K., Nakabayashi N. Adsorption-desorption of proteins on phospholipid polymer surfaces evaluated by dynamic contact angle measurement. J Biomed Mater Res. 29(3):1995;381-387
25. Ishihara K., Nomura H., Mihara T., Kurita K., Iwasaki Y., Nakabayashi N. Why do phospholipid polymers reduce protein adsorption? J Biomed Mater Res. 39:1998;323-330
26. Thull R. Physicochemical principles of tissue material interactions. Biomol Eng. 19(2-6):2002;43-50
27. Kiremitçi M., Gök E., Ateş S. Protein adsorption behaviour of ionogenic poly(HEMA) membranes. a fluorescence study J Biomater Sci Polym Ed. 6(5):1994;425-433
28. Chinn J.A., Ratner B.D., Horbett T.A. Adsorption of baboon fibrinogen and the adhesion of platelets to a thin film deposited by radio-frequency glow discharge of allylamine. Biomaterials. 13(5):1992;322-332
29. Rapoza R.J., Horbett T.A. Postadsorptive transitions in fibrinogen. influence of polymer properties J Biomed Mater Res. 24(10):1990;1263-1287
30. Mulvihill J.N., Faradji A., Oberling, Cazenave J.P. Surface passivation by human albumin of plasmapheresis circuits reduces platelet accumulation and thrombus formation. Experimental and clinical studies. J Biomed Mater Res. 24(2):1990;155-163
31. Eberhart R.C., Clagett C.P. Catheter coatings, blood flow and biocompatibility. Semin Hematol. 28(4 Suppl 7):1991;42-48. (discussion 66-8)
32. Whelan D.M., van der Giessen W.J., Krabbendam S.C., van Vliet E.A., Verdouw O.D., Serruys P.W., van Beusekom H.M.M. Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries. Heart. 83(3):2000;338-345
33. Martel R., Campbell E., Leblanc P., Leclerc G., Taylor A., Vick T. Optimization of parameters affecting radiolabelled DNA oligonucleotide loading onto novel X-cat. phosphorylcholine (PC) coated Biodiv Ysio drug delivery stent Can J Cardiol. 16(Suppl F):2000;112F
34. 32P (Oliglow) in a swine model. Anaheim, CA: American Heart Association's Scientific Sessions, November 11-14, 2001.